Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    PL01 - Opening Plenary: Access and Disparities (Japanese, Mandarin, Spanish Translation Available)

    • 07:00 - 08:00
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL01.01 - Introduction and IASLC Award Presentations

      07:00 - 07:30

      • Abstract

      No abstract available for this presentation

    • +

      PL01.02 - Disparities in Lung Cancer Care Across the Population

      07:30 - 07:40  |  Presenter: Raymond Uyiosa Osarogiagbon

      • Abstract

      Loading...

    • +

      PL01.03 - Disparities in Lung Cancer Care: The Global Burden

      07:40 - 07:50  |  Presenter: Alex Adjei

      • Abstract

      No abstract available for this presentation

    • +

      PL01.04 - Live Discussion with Speakers

      07:50 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    P04 - Early Stage/Localized Disease/Ablative Therapies - Nodule Evaluation

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P04.01 - Presence of Ground Glass Opacity Component is True Determinant of Prognosis in Clinical Stage I Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Akira Hamada

      • Abstract

      Loading...

  • +

    P68 - Tumor Biology and Systems Biology: Basic and Translational Science - Advances in Lung Cancer

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology: Basic and Translational Science
    • +

      P68.12 - Inter-Tumor Heterogeneity of CD44 Expression in Non-Small Cell Lung Cancers / EGFR Mutated Lung Adenocarcinomas

      00:00 - 00:00  |  Presenter: Kenichi Suda

      • Abstract

      Loading...

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

      06:30 - 06:40  |  Presenter: Melissa L Johnson

      • Abstract

      Loading...

    • +

      PL02.02 - Discussant

      06:40 - 06:47  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      PL02.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial

      06:47 - 06:57  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      PL02.04 - Discussant

      06:57 - 07:04  |  Presenter: Charles M Rudin

      • Abstract

      No abstract available for this presentation

    • +

      PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      07:04 - 07:14  |  Presenter: Nasser Altorki

      • Abstract

      Loading...

    • +

      PL02.06 - Discussant

      07:14 - 07:21  |  Presenter: Ichiro Yoshino

      • Abstract

      No abstract available for this presentation

    • +

      PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution

      07:21 - 07:31  |  Presenter: Christine Dorothy Berg

      • Abstract

      Loading...

    • +

      PL02.08 - Discussant

      07:31 - 07:38  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      No abstract available for this presentation

    • +

      PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      07:38 - 07:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

    • +

      PL02.10 - Discussant

      07:48 - 07:55  |  Presenter: Marina Chiara Garassino

      • Abstract

      No abstract available for this presentation

    • +

      PL02.11 - Live Discussion with Speakers

      07:55 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 14:30 - 16:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02A.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

      14:30 - 14:40  |  Presenter: Melissa L Johnson

      • Abstract

      Loading...

    • +

      PL02A.02 - Discussant

      14:40 - 14:47  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      PL02A.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial

      14:47 - 14:57  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      PL02A.04 - Discussant

      14:57 - 15:04  |  Presenter: Charles M Rudin

      • Abstract

      No abstract available for this presentation

    • +

      PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      15:04 - 15:14  |  Presenter: Nasser Altorki

      • Abstract

      Loading...

    • +

      PL02A.06 - Discussant

      15:14 - 15:21  |  Presenter: Ichiro Yoshino

      • Abstract

      No abstract available for this presentation

    • +

      PL02A.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution

      15:21 - 15:31  |  Presenter: Christine Dorothy Berg

      • Abstract

      Loading...

    • +

      PL02A.08 - Discussant

      15:31 - 15:38  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      No abstract available for this presentation

    • +

      PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      15:38 - 15:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

    • +

      PL02A.10 - Discussant

      15:48 - 15:55  |  Presenter: Marina Chiara Garassino

      • Abstract

      No abstract available for this presentation

    • +

      PL02A.11 - Live Discussion with Speakers

      15:55 - 16:00

      • Abstract

      No abstract available for this presentation

  • +

    GA01 - IASLC General Assembly

    • 15:00 - 16:00
    • 9/12/2021
    • Location: Program Auditorium
    • Type: Highlights
    • Track: N.A.
    • +

      GA01.01 - Welcome

      15:00 - 15:00  |  Presenter: Tetsuya Mitsudomi

      • Abstract

      No abstract available for this presentation

    • +

      GA01.02 - Recognition of Outgoing & Incoming IASLC Board of Directors

      15:00 - 15:00  |  Presenter: Tetsuya Mitsudomi, Heather Wakelee

      • Abstract

      No abstract available for this presentation

    • +

      GA01.06 - IASLC President Parting Comments

      15:00 - 15:00  |  Presenter: Tetsuya Mitsudomi

      • Abstract

      No abstract available for this presentation

  • +

    BEDG07 - Lung Ambition Alliance with AstraZeneca - Accelerating the Early Diagnosis of Lung Cancer at Local Level

    • 21:15 - 22:15
    • 9/13/2021
    • Location: Brain Exchange Lounge
    • Not for CME Credit
    • Type: Brain Exchange Discussion Groups
    • Track: N.A.
    • +

      BEDG07.01 - Welcome, Introductions and Session Overview

      21:15 - 21:15

      • Abstract

      No abstract available for this presentation

    • +

      BEDG07.02 - Time for Screening of Lung Cancer Is Now

      21:15 - 21:15

      • Abstract

      No abstract available for this presentation

    • +

      BEDG07.03 - IPN Detection as a Complementary Strategy

      21:15 - 21:15

      • Abstract

      No abstract available for this presentation

    • +

      BEDG07.04 - Potential of AI in Early Lung Cancer Detection

      21:15 - 21:15

      • Abstract

      No abstract available for this presentation

    • +

      BEDG07.05 - Case Studies/Best Practices

      21:15 - 21:15

      • Abstract

      No abstract available for this presentation

    • +

      BEDG07.06 - Discussion/Q&A

      21:15 - 21:15

      • Abstract

      No abstract available for this presentation